Literature DB >> 3519461

Immunoglobulin G (IgG) and IgA subclass pattern of human antibodies to Shigella flexneri and Salmonella serogroup B and D lipopolysaccharide O antigens.

M A Persson, E Ekwall, L Hammarström, A A Lindberg, C I Smith.   

Abstract

The subclass distribution of human serum antibodies to the O-antigenic lipopolysaccharides of Salmonella serogroups B and D and to Shigella flexneri serotypes 1b, 2a, and 4a lipopolysaccharide antigens were analyzed in an enzyme-linked immunosorbent assay with monoclonal antibodies to the immunoglobulin subclasses. The patients had culture-verified Salmonella (17 Swedes) or Shigella flexneri (23 Vietnamese; 11 children and 12 adults) infections. Consecutive samples drawn during 1 year postinfection were investigated. Antibodies to the Salmonella antigens were mainly of the immunoglobulin G1 (IgG1), IgA1, and IgA2 subclasses. For the Salmonella serogroup B O polysaccharide, the IgA1 and IgA2 subclasses had peak values earlier than (6/9) or coinciding with the IgG1 (3/9) peak value. Furthermore, the IgA2 response to Salmonella serogroup B was positively correlated to the duration of the carrier state (P less than 0.001); the corresponding IgA1 response was less well correlated but was still significant (P less than 0.02). In the case of the Shigella flexneri O polysaccharide, specific antibodies appeared mainly in the IgG1 and IgA1 subclasses. Some IgG2 was also found, surprisingly even in very young patients. No subclass shift with time within the immunoglobulin classes was noted in any of the groups.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519461      PMCID: PMC260935          DOI: 10.1128/iai.52.3.834-839.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Shigella and Salmonella diarrhoeal disease.

Authors:  M M Levine
Journal:  Trop Doct       Date:  1979-01       Impact factor: 0.731

2.  Immunoglobulin C-gene expression. I. The commitment to IgG subclass of secretory cells is determined by the quality of the nonspecific stimuli.

Authors:  C Martinez-Alonso; A Coutinho; A A Augustin
Journal:  Eur J Immunol       Date:  1980-09       Impact factor: 5.532

Review 3.  Human IgG subclasses in health and disease. (A review). Part I.

Authors:  F Shakib; D R Stanworth
Journal:  Ric Clin Lab       Date:  1980 Jul-Sep

4.  Distribution of IgA subclasses in sera and bone marrow plasma cells of 21 normal individuals.

Authors:  F Skvaril; A Morell
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

5.  Evaluation of some extraction methods for the preparation of bacterial lipopolysaccharides for structural analysis.

Authors:  A A Lindberg; T Holme
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

6.  Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains.

Authors:  J P Vaerman; J F Heremans
Journal:  Science       Date:  1966-08-05       Impact factor: 47.728

7.  Distribution of IgA 1 and IgA 2 plasma cells in various normal human tissues and in the jejunum of plasma IgA-deficient patients.

Authors:  C André; F André; C Fargier
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

8.  Differentiation of human B cells expressing the IgA subclasses as demonstrated by monoclonal hybridoma antibodies.

Authors:  M E Conley; J F Kearney; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

9.  Application and usefulness of enzyme immunoassay for diagnosis of Salmonella typhimurium infection.

Authors:  K Karlsson; H E Carlsson; R Neringer; A A Lindberg
Journal:  Scand J Infect Dis       Date:  1980

10.  H CHAIN SUBGROUPS OF MYELOMA PROTEINS AND NORMAL 7S GAMMA-GLOBULIN.

Authors:  H M GREY; H G KUNKEL
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

View more
  9 in total

1.  Cloning and characterization of the catalase gene of Neisseria gonorrhoeae: use of the gonococcus as a host organism for recombinant DNA.

Authors:  S R Johnson; B M Steiner; G H Perkins
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Serum IgG subclass antibodies to a variety of food antigens in patients with coeliac disease.

Authors:  M Hvatum; H Scott; P Brandtzaeg
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Kett; P Brandtzaeg
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

4.  Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis.

Authors:  S Jeganathan; D Ufomata; J A Hobkirk; L Ivanyi
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

Review 5.  Selective IgG subclass deficiency: quantification and clinical relevance.

Authors:  R Jefferis; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

6.  Bacteroides-specific IgG and IgA subclass antibody-secreting cells isolated from chronically inflamed gingival tissues.

Authors:  T Ogawa; M L McGhee; Z Moldoveanu; S Hamada; J Mestecky; J R McGhee; H Kiyono
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

7.  Regulation of catalase in Neisseria gonorrhoeae. Effects of oxidant stress and exposure to human neutrophils.

Authors:  H Y Zheng; D J Hassett; K Bean; M S Cohen
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Evidence for long-term memory of the mucosal immune system: milk secretory immunoglobulin A against Shigella lipopolysaccharides.

Authors:  K C Hayani; M L Guerrero; G M Ruiz-Palacios; H F Gomez; T G Cleary
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 9.  Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward.

Authors:  Marcelo B Sztein; Rosangela Salerno-Goncalves; Monica A McArthur
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.